<VariationArchive VariationID="2770861" VariationName="NM_020964.3(EPG5):c.1629_1630del (p.Gly544fs)" VariationType="Deletion" Accession="VCV002770861" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2923835" VariationID="2770861">
      <GeneList>
        <Gene Symbol="EPG5" FullName="ectopic P-granules 5 autophagy tethering factor" GeneID="57724" HGNC_ID="HGNC:29331" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.3-21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="45800581" stop="45967329" display_start="45800581" display_stop="45967329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="43427573" stop="43547304" display_start="43427573" display_stop="43547304" Strand="-" />
          </Location>
          <OMIM>615068</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020964.3(EPG5):c.1629_1630del (p.Gly544fs)</Name>
      <CanonicalSPDI>NC_000018.10:45946709:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="45946710" stop="45946711" display_start="45946710" display_stop="45946711" variantLength="2" positionVCF="45946709" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="43526676" stop="43526677" display_start="43526676" display_stop="43526677" variantLength="2" positionVCF="43526675" referenceAlleleVCF="CCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G544fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.45946710_45946711del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.45946710_45946711del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.43526676_43526677del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.43526676_43526677del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042838.1" sequenceAccession="NG_042838" sequenceVersion="1" change="g.25629_25630del">
            <Expression>NG_042838.1:g.25629_25630del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410858.1" sequenceAccession="NM_001410858" sequenceVersion="1" change="c.1629_1630del">
            <Expression>NM_001410858.1:c.1629_1630del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397787.1" sequenceAccession="NP_001397787" sequenceVersion="1" change="p.Gly544fs">
            <Expression>NP_001397787.1:p.Gly544fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410859.1" sequenceAccession="NM_001410859" sequenceVersion="1" change="c.1629_1630del">
            <Expression>NM_001410859.1:c.1629_1630del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397788.1" sequenceAccession="NP_001397788" sequenceVersion="1" change="p.Gly544fs">
            <Expression>NP_001397788.1:p.Gly544fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020964.3" sequenceAccession="NM_020964" sequenceVersion="3" change="c.1629_1630del" MANESelect="true">
            <Expression>NM_020964.3:c.1629_1630del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066015.2" sequenceAccession="NP_066015" sequenceVersion="2" change="p.Gly544fs">
            <Expression>NP_066015.2:p.Gly544fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1234" sequenceAccession="LRG_1234">
            <Expression>LRG_1234:g.25629_25630del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1234t1" sequenceAccession="LRG_1234t1">
            <Expression>LRG_1234t1:c.1629_1630del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1234p1" sequenceAccession="LRG_1234p1" change="p.Gly544fs">
            <Expression>LRG_1234p1:p.Gly544fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020964.3(EPG5):c.1629_1630del (p.Gly544fs) AND Vici syndrome" Accession="RCV003540448" Version="1">
        <ClassifiedConditionList TraitSetID="9271">
          <ClassifiedCondition DB="MedGen" ID="C1855772">Vici syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23222957</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23674064</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9271" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2298" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Absent corpus callosum cataract immunodeficiency</ElementValue>
                <XRef ID="Absent+Corpus+Callosum+Cataract+Immunodeficiency/81" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with cleft lip/palate, cataract, hypopigmentation and absent corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vici syndrome</ElementValue>
                <XRef ID="MONDO:0009452" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VICIS</ElementValue>
                <XRef Type="MIM" ID="242840" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="448" />
                <XRef ID="448" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">With the current widespread use of multigene panels and comprehensive genomic testing, it has become apparent that the phenotypic spectrum of EPG5-related disorder represents a continuum. At the most severe end of the spectrum is classic Vici syndrome (defined as a neurodevelopmental disorder with multisystem involvement characterized by the combination of agenesis of the corpus callosum, cataracts, hypopigmentation, cardiomyopathy, combined immunodeficiency, microcephaly, and failure to thrive); at the milder end of the spectrum are attenuated neurodevelopmental phenotypes with variable multisystem involvement. Median survival in classic Vici syndrome appears to be 24 months, with only 10% of children surviving longer than age five years; the most common causes of death are respiratory infections as a result of primary immunodeficiency and/or cardiac insufficiency resulting from progressive cardiac failure. No data are available on life span in individuals at the milder end of the spectrum.</Attribute>
                <XRef ID="NBK584989" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EPG5 Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EPG5-Related Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EPG5-Related Vici Syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36228046</ID>
                <ID Source="BookShelf">NBK584989</ID>
              </Citation>
              <XRef ID="1493" DB="Orphanet" />
              <XRef ID="C1855772" DB="MedGen" />
              <XRef ID="MONDO:0009452" DB="MONDO" />
              <XRef Type="MIM" ID="242840" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8021248" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="28871064|MedGen:C1855772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004337547" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23222957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23674064</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly544Alafs*17) in the EPG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EPG5 are known to be pathogenic (PMID: 23222957, 23674064). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EPG5-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPG5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.43526676_43526677del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1855772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8021248" TraitType="Disease" MappingType="XRef" MappingValue="C1855772" MappingRef="MedGen">
        <MedGen CUI="C1855772" Name="Vici syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

